1. A stiff extracellular matrix is associated with malignancy in peripheral neuroblastic tumors. Issue 9 (25th January 2017) Authors: Tadeo, Irene; Berbegall, Ana P.; Navarro, Samuel; Castel, Victoria; Noguera, Rosa Journal: Pediatric blood & cancer Issue: Volume 64:Issue 9(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Advances in emerging drugs for the treatment of neuroblastoma. (2nd January 2017) Authors: Berlanga, Pablo; Cañete, Adela; Castel, Victoria Journal: Expert opinion on emerging drugs Issue: Volume 22:Number 1(2017:Mar.) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial. Issue 4 (April 2017) Authors: Ladenstein, Ruth; Pötschger, Ulrike; Pearson, Andrew D J; Brock, Penelope; Luksch, Roberto; Castel, Victoria; Yaniv, Isaac; Papadakis, Vassilios; Laureys, Geneviève; Malis, Josef; Balwierz, Walentyna; Ruud, Ellen; Kogner, Per; Schroeder, Henrik; de Lacerda, Ana Forjaz; Beck-Popovic, Maja; Bician,... Journal: Lancet oncology Issue: Volume 18:Issue 4(2017:Apr.) Page Start: 500 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Emerging drugs for neuroblastoma. (June 2013) Authors: Castel, Victoria; Segura, Vanessa; Berlanga, Pablo Journal: Expert opinion on emerging drugs Issue: Volume 18:Number 2(2013:Jun.) Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Emerging drugs for neuroblastoma. (June 2013) Authors: Castel, Victoria; Segura, Vanessa; Berlanga, Pablo Journal: Expert opinion on emerging drugs Issue: Volume 18:Number 2(2013:Jun.) Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1). Issue 30 (20th October 2021) Authors: Bellini, Angela; Pötschger, Ulrike; Bernard, Virginie; Lapouble, Eve; Baulande, Sylvain; Ambros, Peter F.; Auger, Nathalie; Beiske, Klaus; Bernkopf, Marie; Betts, David R.; Bhalshankar, Jaydutt; Bown, Nick; de Preter, Katleen; Clément, Nathalie; Combaret, Valérie; Font de Mora, Jaime; George, Sal... Journal: Journal of clinical oncology Issue: Volume 39:Issue 30(2021) Page Start: 3377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Image‐defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy‐induced variation, and impact on surgical outcomes. Issue 11 (25th April 2017) Authors: Avanzini, Stefano; Pio, Luca; Erminio, Giovanni; Granata, Claudio; Holmes, Keith; Gambart, Marion; Buffa, Piero; Castel, Victoria; Valteau Couanet, Dominique; Garaventa, Alberto; Pistorio, Angela; Cecchetto, Giovanni; Martucciello, Giuseppe; Mattioli, Girolamo; Sarnacki, Sabine Journal: Pediatric blood & cancer Issue: Volume 64:Issue 11(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial. Issue 12 (December 2018) Authors: Ladenstein, Ruth; Pötschger, Ulrike; Valteau-Couanet, Dominique; Luksch, Roberto; Castel, Victoria; Yaniv, Isaac; Laureys, Genevieve; Brock, Penelope; Michon, Jean Marie; Owens, Cormac; Trahair, Toby; Chan, Godfrey Chi Fung; Ruud, Ellen; Schroeder, Henrik; Beck Popovic, Maja; Schreier, Guenter; L... Journal: Lancet oncology Issue: Volume 19:Issue 12(2018) Page Start: 1617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Intratumoral immunosuppression profiles in 11q‐deleted neuroblastomas provide new potential therapeutic targets. Issue 2 (19th January 2021) Authors: Coronado, Esther; Yañez, Yania; Vidal, Enrique; Rubio, Luis; Vera‐Sempere, Francisco; Cañada‐Martínez, Antonio José; Panadero, Joaquín; Cañete, Adela; Ladenstein, Ruth; Castel, Victoria; Font de Mora, Jaime Journal: Molecular oncology Issue: Volume 15:Issue 2(2021) Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA. Issue 1 (5th January 2023) Authors: Trinidad, Eva María; Vidal, Enrique; Coronado, Esther; Esteve-Codina, Anna; Castel, Victoria; Cañete, Adela; Gut, Marta; Heath, Simon; Font de Mora, Jaime Journal: Briefings in bioinformatics Issue: Volume 24:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗